Why Invest in the Cannabis Industry
The global cannabis market is estimated to be valued at USD 20.5 billion in 2020 and is projected to reach USD 90.4 billion by 2026, recording a CAGR 1 of 28%. North America accounted for the largest revenue share of 79.6% in 2020. 2
Cannabis and its cannabinoids have been found helpful in treating chronic pain, glaucoma, epileptic seizures and anxiety.
Cannabis has the potential to be used in an array of consumer products, such as beverages, energy drinks, coffee, alcohol, and other edible products.
The fibers and stalks of the plant are used in clothing, construction, body oil and lotions, plastic, and construction materials.
Robust M&A Activity
As of May 2021, capital raises in cannabis have more than tripled, reaching $6 billion, signaling increased confidence in projected aggressive cannabis market growth. 3
1 The compound annual growth rate (CAGR) is the rate of return (RoR) that would be required for an investment to grow from its beginning balance to its ending balance, assuming the profits were reinvested at the end of each period of the investment’s life span.
Statements, estimates and forecasts are subject to significant legal, business, economic, and competitive uncertainties. There can be no assurance that such estimates and/or forecasts will be realized, and these are not indicative of future investment performance. Historical data is not indicative of future performance.
OF SPECIAL NOTE
Pronouncements from the current Administration suggest the Department of Justice may take action against states to prevent them from implementing laws that authorize medical marijuana use, possession, distribution, and cultivation. This action may have a material effect on investment in companies involved in the cannabis industry.
Before investing you should carefully consider the ETF’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained from 888.885.0588. Please read the prospectus carefully before you invest.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. Brokerage commissions will reduce returns. NAVs are calculated using prices as of 4:00 PM Eastern Time. The closing price is the Mid-Point between the Bid and Ask price as of the close of exchange. Closing price returns do not represent the returns you would receive if you traded shares at other times.
Investing involves risk, including possible loss of principal. The cannabis industry is subject to rapidly evolving laws, rules and regulations, and increasing competition which may cause such companies to change business model, shrink or suddenly close. These may limit access to banks, and create significant burdens on company resources due to litigation, enforcement actions, receipt of necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. Possession and use of cannabis is illegal under federal and certain states’ laws, which may negatively impact the value of ETF investments. Where legalized by states, cannabis possession and use remains a violation of federal law. The companies in which the ETF invests are subject to various laws and regulations relating to the manufacture, management, transportation, storage and disposal of cannabis, including health and safety, conduct of operations, and environmental protection. Even if a company’s operations are permitted under current law, they may not be permitted in the future, and a company may not be able to continue operations in its current location. Controlled substance legislation differs significantly between countries and may limit a company’s ability to sell products.
Foreign investing involves social and political instability, market illiquidity, exchange-rate fluctuation, high volatility and limited regulation risks. Emerging markets involve different and greater risks, as they are smaller, less liquid and more volatile than more developed countries. Investments made in small, mid-capitalization and micro-capitalization companies may be more volatile and less liquid due to limited resources or product lines and more sensitive to economic factors. ETF investments will be concentrated in an industry or group of industries, and the value of ETF shares may rise and fall more than more diversified funds. Purchasing and writing put and call options entails greater than ordinary investment risks. Options ownership involves the payment of premiums, which may negatively impact ETF performance. Please see the prospectus for details of these and other risks. Distributed by IMST Distributors, LLC.
Have Watchlists? Log in to see them here or sign up to get started.
No Items in Watchlist
There are currently no items in this Watchlist.
No Saved Watchlists
Create a list of the investments you want to track.
Something went wrong while loading Watchlist.
Recently Viewed Tickers
No Recent Tickers
Visit a quote page and your recently viewed tickers will be displayed here.
- N/A Total Returns
- N/A Consistent Return
- N/A Preservation
- N/A Tax Efficiency
- N/A Expense
Lipper Leaders Key
MarketWatch Dow Jones
Stifel upgrades Aurora Cannabis to hold from sell
Stifel analyst W. Andrew Carter on Monday upgraded Aurora Cannabis Inc. to hold from sell and trimmed his price target to C$2.15 ($1.71) a share from C$2.50 a share after a $173 million financing deal that the cannabis co.
Aurora Cannabis repurchases $20 million of convertible notes to lower interest costs
Aurora Cannabis Inc. said Friday it has repurchased $20 million of convertible bonds in a move aimed at reducing its annual interest costs. The Edmonton, Alberta-based cannabis company said it paid $19.2 millin in cash fo.
Canopy Growth shares slide on wider-than-expected loss
Trulieve posts Q1 loss but revenue tops estimates
Trulieve Cannabis Corp. posted a net loss of $32.0 million, or 17 cents share, for the first quarter, after earnings of $30.1 million, or 24 cents share in the year-earlier period. Excluding transaction, acquisition, inte.
Cannabis company Cronos Group doubles revenue, beats analyst target
Cronos Group said Tuesday its first-quarter net loss narrowed to $16.42 million, or 9 cents a share, from a loss of $146.2 million, or 44 cents a share, in the year-ago quarter. Revenue doubled to $25.03 million from $12.
Stifel cuts cannabis industry view as analysts weigh Tilray
Canopy growth eliminating about 250 jobs in cost-cutting move
Canopy Growth Corp. is laying off about 250 employees as result of cost-cutting measures, a spokesperson for the cannabis company told MarketWatch. As of March 31, the company had 3,084 employees. Canopy Growth on Tuesday.
Akanda buys Portugal unit of Canada’s Flowr
Cannabis company Akanda Corp. said Wednesday it agreed to acquire Portugal-based Holigen from Canada’s The Flowr Corp. for about $28 million, including the assumption of $4.3 million in debt. The deal includes $3 million.
Garden State legal cannabis licenses are taking longer than expected
Cannabis company that DEA is allowing to grow for research purposes to list shares on Nasdaq
UPDATE: Trulieve profit falls short of estimates as it books charges related to Harvest acquisition
Trulieve Cannabis Corp. posted weaker-than-expected adjusted profit for the fourth quarter on Wednesday, as it booked charges and costs related to the acquisition of Harvest Health & Recreation which closed last October. .
Cannabis stocks extend rally after report House planning to vote again on MORE Act that would legalize weed
Cannabis stocks extended their late Thursday-rally premarket Friday, after a report that the U.S. House of Representatives is planning to vote for the second time on the Marijuana Opportunity, Reinvestment and Expungement .
Cannabis stocks rally on flurry of federal moves toward legalization
Stifel reiterates sell rating on Aurora Cannabis after its acquisition of TerrFarma
Stifel analyst W. Andrew Carter on Wednesday reiterated his sell rating for Aurora Cannabis Inc. after the Canadian cannabis company announced plans to buy TerraFarma Inc., the parent company of craft cultivator Thrive Ca.
Corrected Cannabis company Akanda’s stock rockets in trading debut
Green Thumb CEO eyes ‘wonderfully boring’ execution of new market growth plan
NewAge to weigh reverse stock split to regain Nasdaq listing requirement
NewAge Inc. said Friday it has received notice from Nasdaq Stock Market LLC that it is not in compliance with the $1.00 closing bid listing requirement. The Utah-based health and wellness beverage and cannabis company has.
Flowr Corp sells R&D station to Hawthorne Canada
Flowr Corp. said Friday it agreed to sell its Kelowna research and development facility to Hawthorne Canada Ltd., the unit of Scotts Miracle-Gro Co. that specializes in hydroponic solutions. Toronto-based Flowr Corp. sai.
Cannabis company Hexo to cut 180 jobs
Hexo Corp. said Wednesday it is cutting 180 jobs, as part of the Canada-based cannabis company’s cost-cutting plan. The layoffs represent about 14% of the company’s workforce, which was about 1,277, according to the lates.
Another cannabis business development company is set to go public
No Headlines Available
Other News Press Releases
Cannabis ETFs Set to Soar on Passage of Legalization Bill
Cannabis stocks are poised to surge further especially following the legislation passed by the House to legalize marijuana nationwide.
Cannabis ETFs Soar Last Week
Cannabis ETFs have topped the list of best performing ETFs last week on hopes of federal legalization vote.
Peconic Partners Llc Buys MasTec Inc, Dycom Industries Inc, iShares Russell 2000 ETF, Sells .
Peconic Partners Llc Buys MasTec Inc, Dycom Industries Inc, iShares Russell 2000 ETF, Sells McDonald’s Corp, Williams Inc, Southwestern Energy Co
3d Buys FT Cboe Vest U.S. Equity Buffer ETF -October, FT Cboe Vest U.S. .
3d Buys FT Cboe Vest U.S. Equity Buffer ETF -October, FT Cboe Vest U.S. Equity Deep Buffer ETF – October, Dimensional U.S. Core Equity 2 ETF, Sells FT Cboe Vest U.S. Equity Buffer ETF – July, FT Cboe Vest U.S. Equity Deep .
3 Under-the-Radar Cannabis Stocks for 2022
3 Cannabis Beverage Stocks to Buy to Ride the Weed Wave
The Green Gold Rush Is Over In Canopy Growth For Now
Volatility In Tilray Will Likely Continue After Its Recent Merger
Guide to Global X Thematic ETFs
Inside three of Global X. s thematic ETFs and their chances of outperformance ahead.
ETF Areas That Investors Can Consider for May
Considering the current market environment, we highlight some ETF areas for investors to bet on in May.
SNDL Stock Is Need Of a Growth Story and Positive Catalysts
Cannabis ETFs to Surge on Banking Bill Approval in House
On Apr 19, the U.S. House of Representatives okayed legislation that would allow banks to provide services to cannabis companies in states where it is legal.
Cannabis On a Roll: Guide to ETF Investing
Shares of cannabis-related stocks and ETFs continue to be in good shape after a solid run last year.
Thematic Investing Ideas to Boost Your Portfolio Returns in Q2
Here we discuss some ETFs that can lend investors exposure to the thematic investing trends in Q2 in the ongoing year.
Sundial Stock Could Come Under Pressure After Fourth-Quarter Earnings
Top-Performing ETF Areas of Last Week
The passage of the $1.9 trillion COVID-19 relief bill and tame inflation data boosted the markets last week.
Aurora Cannabis Is Speculative — And It Might Take a Breather Soon
Should You Invest in Marijuana Stocks & ETFs Now?
CNBC’s cannabis expert Tim Seymour discusses the outlook for the industry.
Thematic Investing Puts Spotlight on These ETF Areas
Here we discuss some ETFs that can lend investors exposure to the thematic investing trends in 2021.
Marijuana ETFs on a High on Reddit Frenzy
After promoting GameStop (GME) and Silver, Reddit’s discussion has now popularized marijuana stocks like Sundial Growers (up 78.8% on Feb 10) and Tilray (up more than 50% on Feb 10).
No Headlines Available
Top 10 Holdings
|Company||Symbol||Total Net Assets|
|Sundial Growers Inc.||SNDL||16.10%|
|Tilray Brands Inc. Cl 2||TLRY||14.55%|
|OrganiGram Holdings Inc.||OGI||12.13%|
|Cronos Group Inc.||CRON||11.74%|
|Canopy Growth Corp.||CGC||10.54%|
|Aurora Cannabis Inc.||ACB||10.52%|
|MyMD Pharmaceuticals Inc.||MYMD||6.00%|
|AFC Gamma Inc.||AFCG||5.98%|
|Charlotte’s Web Holdings Inc.||CWBHF||5.92%|
The Fund seeks total return performance of the Innovation Labs Cannabis Index. The Fund invests in the component securities of the Index and the Fund also invests at least 80% of its net assets in exchange listed common stock (or corresponding American Depositary Receipts (ADRs) of Cannabis Companies.